ProteoMediX enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies.
Location
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2010
-
Number of employees in Switzerland10-19